Hermetica Superfood Encyclopedia
Sanshishi (Gardenia jasminoides) is a flowering plant used in Japanese Kampo medicine containing bioactive iridoid glycosides, primarily geniposide and gardenoside. These compounds demonstrate antioxidant activity through free radical scavenging mechanisms in preliminary laboratory studies.

Sanshishi refers to the dried ripe fruit of Gardenia jasminoides Ellis, an evergreen shrub in the Rubiaceae family native to subtropical Asia, particularly China, Japan, and Korea. The fruits are processed using various extraction methods including ethanol, ethyl acetate, supercritical CO2, and high-speed counter-current chromatography to isolate iridoids, phenolic compounds, and volatile oils.
The research dossier reveals no human clinical trials, randomized controlled trials, or meta-analyses for Sanshishi (Gardenia jasminoides). Available data focus exclusively on phytochemical characterization and preclinical bioactivity assessments, with no PubMed PMIDs for human studies provided.

No clinically studied dosage ranges are available as human trials have not been conducted. Analytical studies show standardized extracts typically contain 5-6% iridoid glycosides, with geniposide at 56.37 ± 26.24 μg/mg and gardenoside at 49.57 ± 18.78 μg/mg in fruit samples. Consult a healthcare provider before starting any new supplement.
Sanshishi (Gardenia jasminoides fruit) is not consumed as a food for macronutrient value but rather as a medicinal herb; therefore, standard macronutrient data (protein, fat, carbohydrate, fiber per serving) are not typically reported in nutritional databases. Its significance lies in its bioactive phytochemical profile: **Iridoid glycosides (primary active class, ~5–8% of dried fruit by weight):** • Geniposide – the dominant iridoid, reported at approximately 30–80 mg/g of dried fruit depending on cultivar, harvest time, and extraction method; considered the principal bioactive marker compound in Chinese Pharmacopoeia (≥1.8% by HPLC required for quality standard) • Genipin – the aglycone of geniposide, formed by enzymatic hydrolysis in the gut; exhibits higher membrane permeability than geniposide and is considered a key active metabolite • Gardenoside (also called shanzhiside) – typically 5–20 mg/g dried fruit • Scandoside, deacetyl-asperulosidic acid, and other minor iridoids present at lower concentrations **Carotenoid-derived pigments (crocins and related compounds, ~1–3% of dried fruit):** • Crocin-1 (crocetin di-gentiobiosyl ester) – the major water-soluble yellow pigment, approximately 5–25 mg/g dried fruit; this is the same pigment class found in saffron (Crocus sativus) • Crocin-2, crocin-3, and crocetin (the aglycone) present in smaller quantities • These crocins contribute to the fruit's traditional use as a natural food colorant and possess notable antioxidant activity (ORAC values comparable to or exceeding many common dietary antioxidants in vitro) **Phenolic acids and flavonoids (~0.5–2%):** • Chlorogenic acid – approximately 2–10 mg/g dried fruit • 3,5-di-O-caffeoylquinic acid and other caffeoylquinic acid derivatives • Rutin and quercetin glycosides in minor amounts • Protocatechuic acid, vanillic acid, and ferulic acid detected at trace to low mg/g levels **Organic acids:** • Ursolic acid and oleanolic acid (triterpenoid acids) – reported at approximately 1–5 mg/g • Geniposidic acid **Essential oil components (trace, <0.5%):** • Linalool, α-terpineol, and other monoterpene alcohols contributing to aroma **Minerals (approximate, per dried fruit):** • Potassium, calcium, magnesium, iron, zinc, and manganese are present but typically at levels consistent with dried botanical materials (not a significant dietary source at typical medicinal doses of 3–12 g/day) **Vitamins:** • No significant vitamin content has been characterized at pharmacologically relevant levels; the crocins are sometimes loosely associated with provitamin A activity, but crocetin is an apocarotenoid without true vitamin A precursor function. **Bioavailability notes:** • Geniposide has moderate oral bioavailability (~20–30% in animal models) and is hydrolyzed by intestinal β-glucosidase to genipin, which is more readily absorbed and undergoes significant first-pass hepatic metabolism. • Crocins are hydrophilic and have relatively low oral bioavailability; they are partially hydrolyzed to crocetin in the GI tract, which is absorbed more efficiently (crocetin bioavailability estimated at 50–60% in animal studies). • Chlorogenic acid bioavailability is limited (~30% absorbed in the small intestine) with a significant fraction metabolized by colonic microbiota to caffeic acid and other metabolites. • Traditional decoction preparation (boiling in water for medicinal use) efficiently extracts the water-soluble iridoids and crocins but may partially degrade heat-sensitive compounds; co-administration with lipids does not significantly enhance crocin absorption due to their hydrophilic nature.
Sanshishi's primary bioactive compound geniposide acts as an antioxidant by scavenging reactive oxygen species and upregulating endogenous antioxidant enzymes like superoxide dismutase. The iridoid glycosides gardenoside and genipin also contribute to anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-κB) signaling pathways. These compounds may modulate hepatic metabolism through interactions with bile acid synthesis pathways.
Current evidence for sanshishi is limited to preclinical laboratory and animal studies, with no published human clinical trials available. In vitro studies have demonstrated antioxidant activity of geniposide extracts at concentrations of 10-100 μg/mL. Animal studies in rodents suggest potential hepatoprotective effects at doses of 50-200 mg/kg body weight. The evidence quality remains preliminary, requiring human trials to establish therapeutic efficacy and optimal dosing.
Sanshishi is generally considered safe when used traditionally in Kampo formulations, though individual tolerance may vary. No specific drug interactions have been documented in clinical literature, but caution is advised with medications metabolized by cytochrome P450 enzymes. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Potential side effects may include gastrointestinal upset, though systematic safety studies are lacking.